BioStock’s article series on drug development: The Success of Orphan Drug Designation 14 oktober, 2019Getting a pharmaceutical drug approved by regulators is notably very challenging, requiring several years and exorbitant amounts of money. However, recent studies following trends in drug development approval r... LÄS MER!
BioStock’s article series on drug development: Making Treatments More Accessible 10 oktober, 2019The modern history of regulations put in place for ethical, safe and effective drug development gives us a general overview of why such regulations are so important, but it also gives us the idea of how they bu... LÄS MER!
BioStock’s article series on drug development: A Brief History of Regulatory Affairs 7 oktober, 2019In this article series, we have so far uncovered the heavy burdens of time and money placed on the modern drug development process. These, in large part, fall upon biotech companies thanks to stringent regulati... LÄS MER!
BioStock’s article series on drug development: The Challenges 4 oktober, 2019On October 1, BioStock introduced an article series on drug development. In the first post, we became more familiar with the steps involved in the long journey from drug discovery and R&D to clinical develo... LÄS MER!
